Class information for:
Level 1: LOW MOLECULAR WEIGHT HEPARIN//UNFRACTIONATED HEPARIN//ANTI XA ACTIVITY

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1974 2336 31.9 65%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
200 20446 PULMONARY EMBOLISM//VENOUS THROMBOEMBOLISM//DEEP VEIN THROMBOSIS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LOW MOLECULAR WEIGHT HEPARIN Author keyword 56 17% 13% 309
2 UNFRACTIONATED HEPARIN Author keyword 22 22% 4% 90
3 ANTI XA ACTIVITY Author keyword 13 46% 1% 21
4 LOW MOLECULAR WEIGHT HEPARINS Author keyword 13 22% 2% 51
5 TINZAPARIN Author keyword 13 39% 1% 26
6 ENOXAPARIN Author keyword 13 13% 4% 87
7 ANTIFACTOR XA ACTIVITY Author keyword 11 65% 0% 11
8 HEPARIN MONITORING Author keyword 7 67% 0% 6
9 APROSULATE Author keyword 6 80% 0% 4
10 POLYSACCHARIDES THERAPEUTIC USE Author keyword 6 80% 0% 4

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 LOW MOLECULAR WEIGHT HEPARIN 56 17% 13% 309 Search LOW+MOLECULAR+WEIGHT+HEPARIN Search LOW+MOLECULAR+WEIGHT+HEPARIN
2 UNFRACTIONATED HEPARIN 22 22% 4% 90 Search UNFRACTIONATED+HEPARIN Search UNFRACTIONATED+HEPARIN
3 ANTI XA ACTIVITY 13 46% 1% 21 Search ANTI+XA+ACTIVITY Search ANTI+XA+ACTIVITY
4 LOW MOLECULAR WEIGHT HEPARINS 13 22% 2% 51 Search LOW+MOLECULAR+WEIGHT+HEPARINS Search LOW+MOLECULAR+WEIGHT+HEPARINS
5 TINZAPARIN 13 39% 1% 26 Search TINZAPARIN Search TINZAPARIN
6 ENOXAPARIN 13 13% 4% 87 Search ENOXAPARIN Search ENOXAPARIN
7 ANTIFACTOR XA ACTIVITY 11 65% 0% 11 Search ANTIFACTOR+XA+ACTIVITY Search ANTIFACTOR+XA+ACTIVITY
8 HEPARIN MONITORING 7 67% 0% 6 Search HEPARIN+MONITORING Search HEPARIN+MONITORING
9 APROSULATE 6 80% 0% 4 Search APROSULATE Search APROSULATE
10 POLYSACCHARIDES THERAPEUTIC USE 6 80% 0% 4 Search POLYSACCHARIDES+THERAPEUTIC+USE Search POLYSACCHARIDES+THERAPEUTIC+USE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 INTRAVENOUS UNFRACTIONATED HEPARIN 110 46% 8% 178
2 CONTINUOUS INTRAVENOUS HEPARIN 102 60% 5% 110
3 STANDARD HEPARIN 86 38% 8% 178
4 DAILY SUBCUTANEOUS DALTEPARIN 56 81% 1% 34
5 UNFRACTIONATED HEPARIN 54 13% 17% 392
6 LMW HEPARIN 42 94% 1% 15
7 SUBCUTANEOUS HEPARIN 35 26% 5% 116
8 FRAGMIN 31 47% 2% 49
9 CY 216 31 82% 1% 18
10 PROXIMAL VEIN THROMBOSIS 28 39% 2% 57

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Parenteral anticoagulants 2008 259 162 54%
Meta-analysis: Low-molecular-weight heparin and bleeding in patients with severe renal insufficiency 2006 194 49 84%
HEPARIN 1991 775 83 37%
Low-molecular-weight heparins 1997 897 84 32%
Low-Molecular-Weight Heparins in Renal Impairment and Obesity: Available Evidence and Clinical Practice Recommendations Across Medical and Surgical Settings 2009 67 102 47%
Heparin and low-molecular-weight heparin - Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety 2001 481 271 38%
Antifactor Xa Levels versus Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin 2012 14 45 84%
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism 2010 20 50 86%
LOW-MOLECULAR-WEIGHT HEPARIN 1992 607 115 50%
Low-molecular-weight heparin in patients with renal insufficiency 2009 28 99 59%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 THER EUT ADVISORY SERV 6 80% 0.2% 4
2 BURNABY 2 67% 0.1% 2
3 ROYAL PATHOLOGISTS 2 67% 0.1% 2
4 UNITE ECHO DOPPLER 2 67% 0.1% 2
5 KRANKENHAUS OTHEKE WABING 1 100% 0.1% 2
6 UNITE GERIATR AIGUE 1 27% 0.2% 4
7 COAGULAT SPECIAL STUDIES 1 24% 0.2% 4
8 CLIN DISCOVERY HUMAN PHARMACOL 1 40% 0.1% 2
9 MAX RAT OW KLIN 1 40% 0.1% 2
10 ANTITHROMBOSIS SERV 1 25% 0.1% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000248638 CELLULAR INHIBITION//INFECT DIS INVEST SCI//PENTOSAN POLYSULPHATE SODIUM
2 0.0000137207 HEPARIN RESISTANCE//ACTIVATED CLOTTING TIME//ACTIVATED COAGULATION TIME
3 0.0000132197 HEPARIN CONJUGATE//ORAL HEPARIN//MED UIJEONGBU ST MARYS HOSP
4 0.0000124128 THROMBOPROPHYLAXIS//VENOUS THROMBOEMBOLISM//DEEP VEIN THROMBOSIS
5 0.0000112080 COUMARIN EMBRYOPATHY//WARFARIN EMBRYOPATHY//MECHANICAL PROSTHETIC HEART VALVES
6 0.0000103469 REGIONAL CITRATE ANTICOAGULATION//REGIONAL ANTICOAGULATION//CITRATE ANTICOAGULATION
7 0.0000097457 RESIDUAL THROMBOSIS//RECURRENT VENOUS THROMBOEMBOLISM//ANTICOAGULANT RELATED BLEEDING
8 0.0000085749 HEPARIN COFACTOR II//ANTITHROMBIN//ANTITHROMBIN DEFICIENCY
9 0.0000085578 HEPARIN INDUCED THROMBOCYTOPENIA//ARGATROBAN//LEPIRUDIN
10 0.0000079831 SULODEXIDE//INHALED HEPARIN//POLYANIONIC CHARGE